Anne Beaubrun

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Patient Reported Outcomes

Respiratory Syncytial Virus

Replacement Therapy

Top Venues

Journal of medical economics

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Shawn Davies, Emily Boller, Jordan G Chase, Anne Beaubrun, Cynthia Miller, Ivar Jensen
A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses. Journal of medical economics 27 (1) (2024)
Shawn Davies, Emily Boller, Jordan G Chase, Anne Beaubrun, Cynthia Miller, Ivar Jensen
A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses. Journal of medical economics 27 (1) (2024)
Shawn Davies, Emily Boller, Jordan G Chase, Anne Beaubrun, Cynthia Miller, Ivar Jensen
A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses. Journal of medical economics (2024)
Clark Brown, Modupe Idowu, Richard Drachtman, Anne Beaubrun, Irene Agodoa, Andy Nguyen, Kelly Lipman, Olga Moshkovich, Ryan Murphy, M Alex Bellenger, Wally R Smith
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study. BioMed research international 2023 (2023)
Clark Brown, Modupe Idowu, Richard Drachtman, Anne Beaubrun, Irene Agodoa, Andy Nguyen, Kelly Lipman, Olga Moshkovich, Ryan Murphy, M Alex Bellenger, Wally R Smith
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study. BioMed research international 2023 (2023)